Physician profile
Greg A Brown
NPI 1720135346
$4,037.85
in general payments reported to CMS, 2019-2025
18 companies · $599 in 2025
The $599 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $750 · 2020: $343 · 2021: $65.26 · 2022: $748 · 2023: $755 · 2024: $778 · 2025: $599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,009 · Education: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,009.26 |
| Education | $122.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $817.81 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $647.27 | 2022-2024 | Mounjaro, Trulicity, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $587.51 | 2024-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $476.29 | 2022-2024 | Farxiga, Airsupra |
| Janssen Pharmaceuticals, INC | $455.67 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $200.31 | 2020-2023 | Abilify, Sotyktu |
| Abbvie INC. | $160.53 | 2021-2023 | Ozurdex, Linzess, Creon |
| Regeneron Healthcare Solutions, INC. | $118.39 | 2019 | |
| Indivior INC. | $99.87 | 2019 | |
| Astellas Pharma US INC | $99.26 | 2020-2023 | Myrbetriq |
| Pfizer INC. | $97.34 | 2020-2023 | |
| Impel Pharmaceuticals INC. | $86.12 | 2023 | Trudhesa |
| Allergan, INC. | $74.35 | 2020 | |
| Exact Sciences Corporation | $41.88 | 2024 | Cologuard Collection Kit |
| Edwards Lifesciences Corporation | $23.24 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $22.15 | 2020 | |
| Lundbeck LLC | $17.88 | 2024 | Rexulti |
| Amarin Pharma, INC. | $11.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Greg Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.